Skip to main content
The Science

FDA Approval and Safety Standards for Orthokeratology Lenses

DJ
Dr. James Singletary, OD, FIAOMCOD, FIAOMC
January 5, 2026
7
FDA Approval and Safety Standards for Orthokeratology Lenses

If you are considering overnight lenses for your child, it makes sense to ask what FDA approval actually tells you. Which lens was reviewed? What is it approved to do? And what still depends on the fitting, cleaning routine and follow-up care? Those details matter more than an approval badge on its own. This article explains the device records, the difference between temporary vision correction and myopia control, and the questions to bring to your provider.

Ortho-K is prescribed for wear during sleep, so its lens design and instructions differ from those of ordinary daytime contacts. Approval does not remove the possibility of infection or other complications. Understanding the approved use, your doctor’s instructions and the signs that need attention helps you make a considered decision.

What FDA Approval Means for Your Family’s Safety

So, what does it really mean when we say an ortho-k lens is "FDA-approved"? The U.S. Food and Drug Administration (FDA) is the federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. And yes, contact lenses, including ortho-k lenses, are classified as medical devices.

For a device to earn FDA approval, it must go through a scientific and regulatory review appropriate to the device and intended use. The manufacturer has to provide extensive data from laboratory studies and human clinical trials to prove two fundamental things:

  1. It is safe: The device does not pose an unreasonable risk of illness or injury.
  2. It is effective: The device performs as promised and delivers a real clinical benefit.

This isn’t just about paperwork. It’s about a deep, scientific evaluation of the device’s design, materials, manufacturing processes, and performance in real patients. The FDA’s review is exhaustive, and their standards are among the highest in the world. When you choose an FDA-approved ortho-k lens, you’re not just getting a piece of plastic; you’re getting a medical device that has been scrutinized, tested, and validated to meet stringent safety and performance benchmarks. It’s a seal of approval that provides peace of mind, and frankly, it’s a non-negotiable for me as a practitioner.

Think of it like this: you wouldn’t give your child a medication that wasn’t approved by the FDA. The same standard should apply to anything you put in their eyes. This approval is the bedrock of patient safety in the world of orthokeratology.

A Landmark Achievement: FDA Approval for Overnight Vision Correction

Several FDA device decisions mark the development of overnight Ortho-K. Regulatory status applies to a particular device and intended use. An approved overnight lens can still be used for an indication outside its labeling; the provider should explain that distinction.

In 2002, the FDA approved Paragon CRT®, the first lens specifically for overnight orthokeratology. This validated the treatment as a safe and effective method for vision correction.

Euclid's Emerald™ lens followed in 2004, and other designs have since been approved, further establishing the safety of overnight orthokeratology.

The comparison below links to the original FDA records so you can examine the particular device and indication.

See “How to Verify Your Lenses” below for the linked approval records.

These records show how specific lenses reached approval. They do not make every claim about Ortho-K an approved use or remove the need for individual assessment.

Behind the Approval: The Rigorous Testing Process

The FDA approval process is a marathon, involving several stages of scrutiny.

Pre-clinical studies test the lens material's oxygen permeability, durability, and resistance to deposits. Computer simulations model the lens's interaction with the cornea.

A scientist in a quality control lab inspecting a contact lens.

In state-of-the-art labs like this one, every aspect of an ortho-k lens is meticulously tested to ensure it meets the highest standards for safety and quality before it ever reaches a patient’s eye.

Clinical investigations provide information about safety and effectiveness in a defined patient population. Study size and follow-up depend on the particular application; the approval records let you examine the evidence for the device being considered.

Clinical evidence can address questions such as:

  • Efficacy: Does the lens provide the refractive correction described in its intended use?
  • Safety: Are there any adverse events, such as inflammation, infection, or corneal staining? How does the eye health of the trial participants compare to a control group?
  • Fit and Comfort: How well does the lens fit on a variety of corneal shapes? Is it comfortable for overnight wear?

The submitted evidence is evaluated for the device’s intended use. FDA’s explanation of premarket approval describes the review and its scientific requirements.

Post-Market Surveillance: The Safety Watch Doesn’t End

FDA approval isn't the end of the safety story. Post-market surveillance is a critical phase where the FDA continues to monitor the performance of lenses and manufacturers must report any serious adverse events.

This feedback loop allows the FDA to take action if issues arise, from updating labels to recalling products, forming a crucial safety net for patients.

Parents often ask about infection risks. While all contact lenses carry some risk, studies show that with proper hygiene, the risk of microbial keratitis with FDA-approved ortho-k lenses is very low and comparable to other overnight lenses.

Let’s look at the data:

Chart comparing adverse event rates of different contact lens types.

This chart compares the estimated incidence of microbial keratitis, a rare but serious complication, across different types of contact lenses. As you can see, the rate for ortho-k is similar to other approved overnight modalities and remains very low overall. [1]

Ask which lens the provider recommends and what its approval covers. Then review the fitting, cleaning instructions and follow-up schedule. At the clinic, you should have time to practice handling the lenses and ask what to do if they become uncomfortable or your vision changes.

How to Verify Your Lenses Are FDA-Approved

You have the right to know which device is being used. Ask your provider for the lens name, material, patient instructions and the indication that applies to your treatment. FDA records describe particular devices; a program name alone does not identify the lens or its labeling.

Here are examples of official records you can review. They are historical approval records, not a list of lenses supplied by every sleepSEE provider.

Device in the FDA recordDecision dateRecord and what to check
Paragon CRT / CRT 100June 13, 2002P870024/S043: device-specific overnight-wear indications
Euclid Systems Ortho-K, oprifocon AJune 7, 2004P010062: original approval and later supplements
Optimum Infinite Orthokeratology Lenses IIFebruary 10, 2026P240045: approval order and labeling

Check later supplements as well as the original record, because labeling and device details can change. Ask the provider to explain prescription limits, contraindications, care requirements and any use outside the labeled indication.

Your Partner in Safe Myopia Control

Choosing a device is one part of care. The examination, fit, handling instruction and follow-up help the provider assess whether treatment is appropriate for your eyes. Keep the patient instructions and office contact information available, and bring questions to each visit.

Frequently Asked Questions

Does FDA approval mean every Ortho-K treatment has the same indication?

No. Read the particular device's current labeling. Temporary refractive correction and an indication to slow myopia progression are different claims; do not infer one from the other.

Is sleepSEE itself the name of an FDA-approved lens?

sleepSEE is the care program discussed on this site. Ask your participating provider which specific device is prescribed and how its labeling applies to you.

What if my lens becomes uncomfortable?

Remove the lens and contact your provider for concerning symptoms. FDA patient guidance explains symptoms that need attention. Keep scheduled checks even when the routine feels familiar.

Free Download

Free Download: The Science Behind Ortho-K

A plain-language summary of selected clinical studies on orthokeratology and eye growth.

  • Summary of 12 peer-reviewed clinical studies
  • Myopia progression rates with/without treatment
  • Ortho-K vs. atropine vs. multifocal lenses
  • FDA approval history and safety data

Includes sleepSEE email updates. Privacy policy

DJ

Dr. James Singletary, OD, FIAOMC

Dr. James Singletary, OD, FIAOMC is a licensed optometrist and orthokeratology specialist with over 20 years of clinical experience in myopia control, myopia management, orthokeratology, and nonsurgical vision correction. He is the founder of Eye Medics Optometry in Fayetteville, NC and the creator of the sleepSEE ortho-k program.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified eye care professional for diagnosis and treatment of eye conditions. The information provided here should not be used as a substitute for professional medical advice.

Share This Article